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AbstractCardiac depression is one of the most common psychological reactions of patients with acute coronary syndrome (ACS). This study aimed to determine the prevalence of cardiac depression and its related factors among patients with ACS. This 
cross-sectional study was conducted during 2016 in patients with ACS who were admitted to hospitals affiliated to the Mazandaran University of Medical Sciences, Iran. In the present study, 407 patients completed the Cardiac Depression Scale (CDS) within two months (March - June). The data were analyzed by a chi-square test and a general linear model multivariate analysis. According to the results, the mean cardiac depression score in patients with ACS was 109.00 ± 16.49 (CI95: 107.39 to 110.60). Among the participants, 37 (9.1%), 72 (17.7%), and 298 (73.2%) patients had mild, moderate, 
and severe levels of depression, respectively. Although the two-way ANOVA was not significant, but there was a difference between cardiac depression score of a type of ACS. Given the high prevalence of cardiac depression among these patients, it is necessary to develop measures for routine screening in cardiac treatment units. 
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1.  Introduction
At the beginning of the twentieth century, cardiovascular 
diseases (CVDs) constituted less than 10% of deaths in the 
world. However, with the passing of time and the advent 
of the industrial revolution and its effects on the social 
and economic aspects of communities, the incidence of 
this disease increase1. Acute myocardial infarction (AMI) 
is the most common cardiovascular disease. It has the 
second rank among diseases in developed and developing 
countries2. Approximately 1.1 million cases of AMI occur 
each year in the United States and 44.81% deaths are due 
to AMI3. In Iran, CVDs are the leading cause of death and 
AMI is the cause of half of the mortality rate attributed to 
CVDs4. Every year, about 3.6 million people are admitted to 
hospitals of the Ministry of Health and Medical Education 
due to CVDs, and CVDs account for about 46% of deaths 
thus far5. Acute coronary syndrome (ACS), in addition 
to physical consequences, has many psychological 
consequences6. Depression, delirium, cognitive disorders, 
fear, anxiety, and stress are among the psychological 
reactions of ACS patients, and depression is one of the 
most common psychological consequences among these 
patients7,8. The physiological mechanisms accounting for 
this association are unclear. Hypothalamic–pituitary–
adrenal dysregulation, diminished heart rate variability, 
altered blood platelet function and noncompliance with 
medical treatments have been proposed as mechanisms 
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underlying depression and cardiovascular disease. 
Recent evidence also suggests that reduced baroreflex 
sensitivity, impaired immune function, chronic fatigue 
and the co-morbidity of depression and anxiety may 
be involved in the relationship between depression and 
cardiovascular dysregulation9. Depression reduces the 
patients’ desire to follow the recommendations for the 
reduction of CVD risk factors10. This has a negative 
impact on the course of the disease as well as the physical 
and psychological recovery process of the patients6,11,12. 
According to previous studies, the rate of depression in 
patients after AMI is three times higher than the general 
population13,14. The results of the study by Hosseini et al. 
showed that the prevalence of depression in the first 48 
hours after AMI was 60.7%15. AMI is a life-threatening 
disease: thus, it can be expected to have a stressful role in 
the development of depression. AMI, due to limiting the 
physical activity of the individual, also causes depression 
as its secondary effect. In the past 40 years, more than 
60 prospective studies have examined the relationship 
between depression and CVDs. Based on the findings of 
these studies, the incidence of depression among patients 
with CVD was three times higher than that in the general 
population16,17. Bayani et al18 reported the prevalence of 
depression using the Hamilton Depression Scale in 238 
patients with CVDs as 41.2%. Carney et al.19 reported the 
prevalence of depression among 70 patients with coronary 
syndrome using the DIS questionnaire as 23%. Due to the 
direct or indirect effect of depression on the prognosis 
of heart disease, screening, and treatment of depression 
in these patients seems necessary. According to a review 
study, the majority of cardiac patients use tricyclic 
antidepressants (TCAs), one of TCAs and bupropion 
and selective serotonin reuptake inhibitors (SSRIs) to the 
treatment of depression20. Studies on the prevalence of 
depression among patients with CVDs in Iran are very 
scattered and the Cardiac Depression Scale (CDS) was 
not used to obtain more accurate and correct data on the 
symptoms and intensity of cardiac depression in patients 
with ACS. Therefore, this study aimed to determine the 
prevalence of cardiac depression and its related factors in 
patients with ACS.
2.  Material and Methods 
This cross-sectional study was conducted in 2016 
(March - June) on 407 patients with ACS who were 
admitted to the CCU of Imam Reza and Fatimeh Zahra 
Hospitals in Sari, Iran. The participants were selected 
via simple random sampling method. The adequacy of 
the sample size was determined based on the two-sided 
significance level of (α = 0.05) and 80% power (d = 0.3). 
The diagnosis and admission criteria were determined by 
the cardiologist in relation to electrocardiographic (ECG) 
changes in ST segment, ST elevation MI (STEMI). STEMI 
is characterized as ST elevation of more than 0.2 mV in 
leads V1-V4 or over 0.1 mV in leads I, II, III, aVL, aVF, 
V5, and V6. Non-ST-elevation myocardial infarction 
(NSTEMI) is characterized as the existence of angina for 
more than 20 minutes along with an increase in a cardiac 
biochemical marker of myocardial necrosis (troponin or 
creatine kinase-MB), ≥10 mm but <20 mm in V1–V4, 
and ECG changes in ST segment depression ≥10 mm 
depression at 80 ms following the J point and inverted T, 
and pathological Q waves [duration _0.03 s amplitude Q: 
R ratio 25%]21. Patients with mental, emotional, and verbal 
problems and reduced consciousness were excluded from 
the study.
2.1 Instruments 
The demographic data (age, gender, economic, and 
educational level) and medical record form (blood 
pressure and blood lipid, history of alcohol and drug use, 
history of depression, level of activity, type of ACS, stroke 
location, and history of previous illness) was completed 
by the participants.
The Cardiac Depression Scale (CDS) by Hare et al.22 
was designed specifically to assess depression in patients 
with CVDs. The CDS includes 26 items that measure 
variables such as activity, focus, rest, mind, emotions, and 
the difficulties of life. This tool was scored based on a Likert 
scale ranging from strongly disagree1 to strongly agree7. 
Total scores are calculated as the sum of the scores of each 
item and range from 26 to 182. Higher scores indicated 
more severe depression23. The validity of the CDS was 
assessed and confirmed through content validity. The 
reliability of the instrument was confirmed by a study on 
heart diseases in Australia with Cronbach’s alpha of 0.90; 
moreover, a 0.73 relationship with the Beck Depression 
Inventory (BDI) was reported in this population24. In this 
study, the internal consistency of the questionnaire was 
calculated using Cronbach’s alpha coefficient (α = 0.73).
2.2 Data Analysis
Statistical analysis was performed using SPSS22 (SPSS 
Inc., Chicago, IL, USA). The Kolmogorov-Smirnov test 
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was used to assess the normal distribution of quantitative 
data. Descriptive and inferential statistics (chi-square, 
general linear model: univariate analysis of variance) were 
used for data analysis. The statistical significance level of 
all tests was considered as less than 0.05. 
2.3 Ethical Consideration
The present study was approved by the ethics committee of 
the associated university in 2015. Patients were informed 
of the study aims and procedures, and that participation 
was voluntary and would not affect medical care before 
signing an informed consent form. Patient confidentiality 
was ensured by completing all study procedures in a 
quiet treatment area. To ensure that a broad cross-section 
of patients was allowed to participate in the study, a 
trained research assistant who was part of the study team 
provided support when needed. All personal data were 
de-identified by assigning codes to the participants.
3.  Results 
According to the results of this study, the mean ± SD of 
the age of patients with ACS in the study was 63.72 ± 
16.37 years (95% CI: 65.32 to 62.12). The mean cardiac 
depression scores in patients with ACS was 109.00 ± 16.49 
(95% CI: 107.39 to 110.60), and 37 (9.1%), 72 (17.7%), 
and 298 (73.2%) of the patients had mild, moderate, and 
severe depression levels, respectively. Table 1 shows the 
association of demographic variables with the type of 
ACS.
According to chi-square test (Table 1), gender (p 
= 0.03) and smoking status (p = 0.006) had statistically 
Table 1.    Association of demographic characters with type of ACS 
p-ValueNSTEMI (n=65)STEMI (n=213)UA (n=129)Variable
0.0345 (20.1%)114 (50.9%)65 (29%)Male (n=224)Sex
20 (10.9%)99 (54.1%)64 (35%)Female (n=183)
0.0618 (14.3%)61 (48.4%)47 (37.3%)Weak (n=126)Economic Status
34 (20.2%)80 (47.6%)54 (32.1%)Intermediate (n=168)
13 (12.3%)68 (64.2%)25 (23.6%)Good (n=106)
  0  4 (57.1%)  3 (42.9%)Well (n=7)
0.8037 (16.7%)112 (50.7%)72 (32.6%)Illiterate (n=221)Education status
26 (14.6%)98 (55.1%)54 (30.3%)Diploma-BS (n=178)
  2 (25.0%)  3 (37.5%)  3 (37.5%)MCs and upper (n=8)
0.2730 (13.6%)122 (55.5%)68 (30.9%)Yes (n= 220)Hyperlipidemia
35 (18.7%)91 (48.7%)61 (32.6%)No (n= 187)
0.00638 (22.9%)81 (48.8%)47 (28.3%)Yes (n= 166)Smoking
27 (11.2%)132 (54.8%)82 (34.0%)No (n= 241)
0.40614 (18.2%)35 (45.5%)28 (36.4%)Yes (n=77)History of alcohol use
51 (15.5%)178 (53.9%)101 (30.6%)No (330)
0.58348 (16.2%)151 (50.8%)98 (33%)Yes (n=297)History of heart disease in 
family 17 (15.5%)62 (56.4%)31 (28.2%)No (n=110)
0.5117 (13%)72 (55%)42 (32.1%)Yes (n=131)Family depression history
48 (17.4%)141 (51.1%)87 (31.5%)No (n=276)
0.36425 (19.7%)65 (51.2%)37 (29.1%)Yes (n=127)Candidate of CABG
40 (14.3%)148 (52.9%)92 (32.9%)No (n=280)
0.46813 (17.6%)42 (56.8%)19 (25.7%)Yes (n=74)CHFPast medical history
52 (15.6%)171 (51.4%)110 (33%)No (n=333)
0.36618 (12.5%)78 (54.2%)48 (33.3%)  Yes (n=144)Diabetes
47 (17.9%)135 (51.3%)81 (30.8%)  No (n=263)
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significant differences among ACS types. Multifactorial 
ANOVA test results (Table 2) showed that the mean 
cardiac depression score in patients with CVD with UA 
(106.40 ± 18.36), STEMI (110.91 ± 14.67), and NSTEMI 
(107.86 ± 17.62) did not have a significant difference [eta 
= 0.002, p = 0.694, F (401, 1) = 1.04].
4.  Discussion 
Previous researchers suggested that depression may be 
a risk factor for coronary heart disorders (CHD)25. The 
more accurate evaluation showed that depression affects 
the automatic adjustment of the heart, sub-chronic 
inflammation, cardiovascular endothelial function, 
platelet function, and omega fatty acids levels26. Therefore, 
like diabetes, reduced physical activity, or weight gain, 
depression is among the risk factors for CVD and is 
perhaps even more important than some of them27. 
Of the 407 patients under study, 37 (9.1%), 72 (17.7%), 
and 298 (73.2%) of the patients had mild, moderate, 
and severe depression levels, respectively. These results 
were consistent with the findings of similar studies24,28,29. 
Moraska et al.30 studied patients with CVDs admitted to the 
emergency unit using the Patient Health Questionnaire-9 
(PHQ-9) and reported that 15% of patients had major 
depression and 26% had mild depression. Moreover, 
Blumenthal et al.31 assessed patients undergoing coronary 
artery bypass grafting (CABG) using the Center for 
Epidemiologic Studies-Depression (CES-D) Scale. They 
reported that 26% of patients had minor depression and 
12% had severe depression which was not consistent 
with the present study results31. A possible cause of this 
inconsistency can be the type of instrument used to 
measure depression which was not designed specifically 
for cardiac patients. The existence of one or more than 
one indicator has a significant influence on the severity 
of depression. Consideration of this matter can, on the 
one hand, influence the process of assessment and the 
use of specific high sensitivity tools for the assessment 
of depression severity in patients with CVD, and on the 
other hand, through the consideration of its effect, impact 
the treatment process. Depression is the most important 
obstacles to treatment of heart diseases because it leads to 
patients’ lack of acceptance of the disease and decreased 
motivation to continue the treatment, and it also has a 
negative impact on the prognosis of CVD32. The impact 
mechanisms of behavior in this disorder is that these 
patients, due to depression, have reduced physical activity, 
reduced self-care, increased alcohol and tobacco use, are 
less likely to seek medical services, and leave rehabilitation 
programs incomplete33. Therefore, early detection and 
management of this common disease are very valuable 
and important in the treatment of patients. In this study, 
gender (p = 0.03), and smoking (p = 0.006) had statistically 
significant differences among of ACS types regarding the 
frequency of depression. This result was consistent with 
that of the studies by Bayani et al.18 and Safai et al.34 which 
were conducted on patients with heart disease and CHD. 
In another study conducted on 108 patients with CVDs 
hospitalized in Rasht, Iran, using the CDS, no statistically 
significant relationship was found between gender and 
severity of depression35. This finding was inconsistent 
with the present study. This difference may be due to the 
differences in sample size and the evaluation of all CVDs 
in this study. Nevertheless, in the present study, only a 
specific and common category of CVDs was taken into 
account. In general, most studies were conducted with 
common psychiatry tools for evaluation of depression. 
Given that the instrument used in this study (CDS) was 
much more accurate and specific to these patients, it is 
suggested that future studies be conducted using this 
tool on a wider scale, on other types of CVDs, and with a 
longer duration of follow-up (even after discharge). 
5.  Study Limitations
During the period of the study, only patients in the 
mentioned centers were monitored and the outpatients 
who referred for examinations were not included in the 
study. Also, all of the patients with the previous history 
Table 2.    Differences among type of ACS based on cardiac depression scores
Type of ACS Mean (SD) 95% CI F p
Unstable Angina (UA) 106.4031 (18.363) 103.20 to 109.60
1.04 0.694
ST segmentation elevation MI (STEMI) 110.9155 (14.673) 108.93 to 112.89
ST segmentation elevation MI (STEMI) 107.8923 (17.629) 103.52 to 112.26
Total 109.0025 (16.492) 107.39 to 110.60
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of disease and family history are included to study that 
may have an effect on the level of depression. Given that 
the hospitalization factor and its related measures may 
affect depression, the severity of depression obtained in 
this study cannot be extended to all patients with CVDs. 
Thus, it is suggested that this factor is considered in future 
studies. 
6.  Conclusion
Given the high prevalence of depression among patients 
with CVDs, it is necessary to develop routine screening 
measures in cardiac treatment units, so that with the early 
diagnosis and treatment of this disorder, faster recovery 
and quality of life improvement can be achieved among 
these patients. Therefore, cardiologists’ and nurses’ role in 
this regard is crucial.
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